LEUKEMIA, MYELOID
Clinical trials for LEUKEMIA, MYELOID explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOID trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells deployed to hunt down lingering cancer after transplant
Disease control Recruiting nowThis early-stage study is testing a new therapy that uses specially trained immune cells from a donor to try to prevent blood cancers from coming back after a stem cell transplant. The goal is to see if these 'memory-like' natural killer (NK) cells, given with a supporting drug, …
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
First patients to receive experimental 'Memory' immune cell therapy for blood cancer
Disease control Recruiting nowThis is a first-in-human study to test the safety of a new type of immune cell therapy for adults with acute myeloid leukemia (AML). Researchers will give patients specially trained 'memory-like' natural killer (NK) cells along with a standard drug called venetoclax, aiming to be…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Two-Pronged attack: new leukemia drug strategy aims for deeper remission
Disease control Recruiting nowThis study is testing a new drug, asciminib, for adults newly diagnosed with a slow-growing type of blood cancer called chronic myeloid leukemia (CML). The goal is to see if asciminib alone can drive the cancer into a very deep remission. If it doesn't work well enough after two …
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE2 • Sponsor: Augusta University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
First patients to try new pill for Tough-to-Treat leukemia
Disease control Recruiting nowThis is the first time researchers are giving a new oral drug called BH-30236 to people. The study aims to find a safe dose and see if the drug can help control two aggressive blood cancers—acute myeloid leukemia or myelodysplastic syndrome—that have come back or haven't responde…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: BlossomHill Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug cocktail tested for aggressive leukemia that has returned
Disease control Recruiting nowThis early-stage trial is testing whether adding an experimental drug called ziftomenib to standard leukemia treatments is safe and tolerable for patients. It focuses on adults with acute myeloid leukemia (AML) that has returned or not responded to prior therapy and has specific …
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC